Middle East and Africa Nucleic Acid Isolation and Purification Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Customize Your Report Customize Your Report Buy Now Buy Now Free Sample Report Free Sample Report
Home Healthcare Middle East And Africa Nucleic Acid Isolation Purification Market
Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Middle East and Africa Nucleic Acid Isolation and Purification Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

  • Healthcare
  • Published Report
  • Nov 2024
  • MEA
  • 350 Pages
  • No of Tables: 389
  • No of Figures: 48
Buy Now Buy Now

Middle East And Africa Nucleic Acid Isolation Purification Market

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period
 2025 –2032
Diagram Market Size (Base Year)
 USD 225.03 Million
Diagram Market Size (Forecast Year)
 USD 396.75 Million
Diagram CAGR
 %
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Request For Unlock

Middle East and Africa Nucleic Acid Isolation and Purification Market Segmentation, By Product (Instruments, Kits, and Reagents), Method (Magnetic Bead-Based Isolation and Purification, Column -Based Isolation and Purification, Reagent-Based Isolation and Purification, and Others), Type (Next Generation Sequencing (NGS), Genomic DNA Isolation and Purification, Total RNA Isolation and Purification, PCR Clean-Up, Plasmid DNA Isolation and Purification, Messenger RNA Isolation and Purification, Circulating Nucleic Acid Isolation and Purification, MicroRNA Isolation and Purification, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research, and Others), Sample Type (FFPE Samples, Blood Cells, Bacteria, Yeast, and Plants, Cell-Free Samples, Cultured Cells, Mammalian Cells, Brain and Kidney Tissue, and Others), End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Contract Development and manufacturing Organization (CDMO), Academic/Research Institutes, and Others) - Industry Trends and Forecast to 2032

Nucleic Acid Isolation and Purification Market

Nucleic Acid Isolation and Purification Market Analysis

The increasing prevalence of genetic disorders is a significant driver in the Middle East and Africa nucleic acid isolation and purification market, as it fuels the demand for advanced diagnostic and therapeutic solutions essential for early detection, accurate diagnosis, and personalized treatment strategies. According to a news article published by BGI Genomics, 5.2% of the global population carry hemoglobin abnormalities, resulting in 300,000 to 400,000 children born with severe hemoglobinopathies annually. The increasing number of hemoglobinopathies acts as a driver for the growth of the market.

Nucleic Acid Isolation and Purification Market Size

 The Middle East and Africa nucleic acid isolation and purification market is expected to reach USD 396.75 million by 2032 from USD 225.03 million in 2024, growing at a CAGR of 8.0% in the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Nucleic Acid Isolation and Purification Market Trends

“Advancement of Automation and High-Throughput Technologies”

As the demand for faster, more efficient, and scalable nucleic acid extraction methods rises, automated systems are becoming crucial in handling large volumes of samples. These automated solutions streamline laboratory workflows, reduce manual labor, and enhance reproducibility, making them highly valuable in genomics, clinical diagnostics, and biotechnology applications. High-throughput platforms allow simultaneous processing of numerous samples, which is vital for large-scale studies, including those related to precision medicine and next-generation sequencing. Additionally, these advancements improve consistency in results, reduce the risk of human error, and accelerate research timelines. Automation also supports the growing trend of personalized medicine, enabling more efficient extraction and analysis of genetic material for individualized treatment plans. The ability to perform high-quality nucleic acid purification at scale is driving the expansion of this trend regionally.

Report Scope and Nucleic Acid Isolation and Purification Market Segmentation           

Attributes

Nucleic Acid Isolation and Purification Key Market Insights

Segments Covered
  • By Product: Instruments, Kits, and Reagents
  • By Method: Magnetic Bead-Based Isolation and Purification, Column -Based Isolation and Purification, Reagent-Based Isolation and Purification, and Others
  • By Type: Next Generation Sequencing (NGS), Genomic DNA Isolation and Purification, Total RNA Isolation and Purification, PCR Clean-Up, Plasmid DNA Isolation and Purification, Messenger RNA Isolation and Purification, Circulating Nucleic Acid Isolation and Purification, MicroRNA Isolation and Purification, and Others
  • By Application: Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research, and Others
  • By Sample Type: FFPE Samples, Blood Cells, Bacteria, Yeast, and Plants, Cell-Free Samples, Cultured Cells, Mammalian Cells, Brain and Kidney Tissue, and Others
  • By End User: Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Contract Development and manufacturing Organization (CDMO), Academic/Research Institutes, and Others

Countries Covered

South Africa, Saudi Arabia, U.A.E., Qatar, Egypt, Kuwait, Bahrain, Oman, Rest of Middle East and Africa

Key Market Players

Merck KGaA (Germany), Cutiva (Danaher Corporation) (U.S.), Meridian Bioscience, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), PerkinElmer Inc. (U.S.), Illumina Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc. (U.S.), QIAGEN (Netherlands), Takara Bio Inc. (Japan), Promega Corporation (U.S.), MACHEREY-NAGEL GmbH & Co. KG (Germany), New England Biolabs (U.S.), Omega Bio-tek, Inc. (U.S.), Zymo Research Corporation (U.S.), Analytik Jena GmbH+Co. KG (Germany), MagGenome Technologies Pvt. Ltd. (India), AUTOGEN INC. (U.S.), Xi'an Tianlong Science and Technology Co., Ltd. (China), PCR Biosystems (UK), Sage Science, Inc. (U.S.), and ALS (Australia) among others

Market Opportunities

  • Rise in Technological Advancements and Automation
  • Increasing adoption of Next-Generation Sequencing (NGS)

Value Added Data Infosets

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Nucleic Acid Isolation and Purification Market Definition

The nucleic acid isolation and purification market refers to the sector focused on the extraction and purification of nucleic acids (DNA, RNA, and other genetic material) from biological samples for various applications, including molecular biology research, clinical diagnostics, forensic analysis, and biotechnology. This market encompasses a wide range of techniques and products such as reagent kits, automated systems, and laboratory equipment used to isolate and purify nucleic acids with high precision and efficiency. Key drivers include the growing demand for personalized medicine, advancements in genomics research, the increasing prevalence of genetic disorders, and the expansion of applications in areas like cancer research, infectious disease diagnostics, and genetic testing. The market is also influenced by technological innovations, such as Next-Generation Sequencing (NGS), which requires highly refined nucleic acid purification methods to ensure the accuracy and quality of sequencing results. The rise in research and clinical applications in emerging markets, along with the increasing number of biotechnology and pharmaceutical companies, contributes to the market’s growth.

Nucleic Acid Isolation and Purification Market Dynamics:

Drivers  

  • Increasing Prevalence of Genetic Disorders

The increasing prevalence of genetic disorders is a significant driver in the Middle East and Africa nucleic acid isolation and purification market, as it fuels the demand for advanced diagnostic and therapeutic solutions essential for early detection, accurate diagnosis, and personalized treatment strategies. As genetic disorders, including conditions such as cystic fibrosis, Huntington’s disease, and various forms of cancer, continue to affect millions worldwide, the need for precise and reliable nucleic acid isolation techniques becomes paramount. These techniques are critical for extracting high-quality DNA and RNA from patient samples, which are subsequently used in a variety of molecular diagnostics, including Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and other genomic analyses that identify genetic mutations and biomarkers. The surge in genetic research and the push towards personalized medicine necessitate robust nucleic acid purification methods to support the development of targeted therapies and gene therapies, thereby enhancing patient outcomes. The rising incidence of genetic disorders drives investments in the biotechnology and pharmaceutical sectors, leading to the expansion of laboratories and research facilities that rely on efficient nucleic acid isolation technologies. Consequently, the interplay between the rising prevalence of genetic disorders and the advancement of molecular diagnostic technologies propels the growth of the nucleic acid isolation and purification market, driving innovation, expanding market reach, and fostering Middle East and Africa collaborations to address the challenges posed by genetic diseases effectively.

For instance,

  • In February 2024, according to an article, ‘Global distribution of β-thalassemia mutations: An update’, globally, approximately 60,000 newborns are born with the β-thalassemia major per year, with the majority living in developing countries and constituting about 1.5 % of the total population. It is the most common autosomal recessively inherited blood disorder. Hence, increasing cases of genetic disorders act as a driver in the growth of the market.

The rising occurrence of genetic disorders strongly drives the regional demand for nucleic acid isolation and purification, as these methods are essential for accurate diagnostics, early detection, and personalized treatment approaches. High-quality DNA and RNA extraction is crucial for advanced molecular analyses like NGS and PCR, which identify genetic mutations and support targeted therapies. Also, progress in genomics and gene-editing techniques heighten the need for precise purification systems that maintain genetic material integrity, fostering innovation and international collaboration to address the growing burden of genetic conditions.

  • Increasing Demand for Diagnostic Testing

The growing demand for diagnostic testing is a key driver in the Middle East and Africa nucleic acid isolation and purification market, as more healthcare providers and researchers rely on these techniques to extract high-quality genetic material for a range of applications. Diagnostic testing for infectious diseases, cancer, genetic disorders, and other health conditions requires precise and rapid nucleic acid isolation to obtain DNA and RNA samples that enable accurate, reliable results. This demand is further fueled by the expansion of molecular diagnostics and advancements in technologies such as PCR, Next-Generation Sequencing (NGS), and CRISPR, all of which depend on purified nucleic acids for detecting pathogens, identifying mutations, and guiding personalized treatment decisions. Also, the rise in routine screening, preventive testing, and decentralized testing models such as point-of-care diagnostics has increased the volume of testing, thereby boosting the need for scalable and efficient nucleic acid isolation and purification solutions.

For instance,

  • In March 2024, according to a news article published by Springer Nature, demand for diagnostic testing surges significantly with rising transmission rates and potential outbreak scenarios. High transmission settings, such as densely populated areas or environments with close-contact interactions, require frequent and rapid testing to manage virus spread effectively. As testing becomes central to early detection, contact tracing, and monitoring of infection rates, nucleic acid testing systems, particularly automated ones, are increasingly vital. The findings underscore that the demand for fast, accurate diagnostic testing will continue to grow, driven by the need for effective outbreak control and public health safety

The surge in diagnostic testing drives the nucleic acid isolation and purification market by creating a high demand for quality DNA and RNA extraction essential for accurate molecular diagnostics. With advancements in techniques like PCR and NGS and the rise in routine and point-of-care testing, the need for efficient, scalable purification methods continues to expand, supporting timely and precise disease detection and personalized care.

Opportunity

  • Rise in Technological Advancements and Automation

Technological advancements and automation are driving significant growth opportunities in the Middle East and Africa nucleic acid isolation and purification market by enhancing accuracy, speed, and scalability in genetic research and diagnostics. Innovations like fully automated extraction systems, high-throughput sequencing, and microfluidics reduce manual intervention, minimizing human error and improving consistency in sample processing. These advancements cater to the growing demand in genomics, proteomics, and personalized medicine by enabling labs to process larger sample volumes with precision and efficiency. Automation allows for integration with downstream analysis tools, creating seamless workflows that save time and reduce costs for laboratories. This enhanced throughput capability supports the expanding applications of nucleic acid-based diagnostics, especially in oncology, infectious diseases, and genetic disorder screening. As these technologies evolve, they also facilitate real-time monitoring and remote accessibility, which are particularly beneficial for decentralized and point-of-care testing, further broadening market growth potential. As automation becomes more accessible, it opens doors for more research institutions, clinical labs, and biotechnology firms to adopt sophisticated nucleic acid isolation and purification technologies, accelerating discovery and innovation across various fields.

For instance,

  • In December 2023, according to the article published by Technology Networks, Thermo Fisher Scientific Inc., a global leader in scientific services, has launched the Thermo Scientific KingFisher Apex Dx, an automated nucleic acid purification instrument, along with the Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit. These products work together to enable the isolation and purification of viral and bacterial pathogens from respiratory samples. Designed for In Vitro Diagnostic (IVD) and In Vitro Diagnostic Regulation (IVD-R) compliance, these automated solutions provide laboratories with enhanced reliability for downstream testing results.

The rapid advancements in technology and automation are transforming the nucleic acid isolation and purification market by boosting accuracy, efficiency, and integration with downstream processes. These innovations enable labs to meet growing demand across genomics, diagnostics, and personalized medicine with higher throughput and reduced costs. As these technologies become more widely accessible, they expand research and diagnostic capabilities, driving broader adoption in labs and institutions worldwide ultimately accelerating progress across numerous scientific and medical fields.

Restraint/Challenge

  • Risks Associated with Sample Contamination

The risk of sample contamination acts as a major restraint in the Middle East and Africa nucleic acid isolation and purification market, as even slight contamination can compromise the integrity and accuracy of DNA or RNA samples, leading to unreliable results. Contaminated samples may interfere with downstream applications such as Next-Generation Sequencing (NGS) or PCR, affecting diagnostics, research outcomes, and therapeutic developments. This poses significant challenges for laboratories, particularly in high-throughput settings, as contamination can increase costs, time, and resources required for retesting and validation. As a result, maintaining sample purity becomes crucial, and the need for highly reliable and contamination-free isolation systems drives continuous innovation in the market.

For instance,

  • In January 2023, according to an article published by Oxford Academic, laboratory contamination had severe and widespread negative impacts on both diagnostic testing and laboratory staff. These impacts extend far beyond an individual patient’s sample, possibly jeopardizing the integrity of a multitude of patient samples and instruments.

The risk of sample contamination hinders the nucleic acid isolation and purification market by compromising the accuracy and reliability of results, leading to increased costs and delays. This challenges laboratories to maintain high standards of purity, driving demand for more reliable and contamination-resistant purification systems. The persistent concern over contamination imposes an additional burden on laboratories in terms of operational protocols and resource allocation.

Nucleic Acid Isolation and Purification Market Scope

The nucleic acid isolation and purification market is segmented on the basis of product, method, type, application, sample type, end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  •  Instruments
    • Type
      • Homogenizer
      •  Spectrophotometers
      •  Fluorometers
      •  Others
      • Modality
      •  Benchtop
      •  Standalone
      • Usability
      •  Automated
      •  Manual
  •  Kits
    •  DNA Isolation & Purification Kits
      • Magnetic Bead-Based Kit
        •  Viral/Pathogen Nucleic Acid Isolation Kit
        •  Plant DNA Isolation Kit
        •  Cell-Free Total Nucleic Acid Kit
        •  Cell-Free DNA Isolation Kit
      • Column-Based Kit
        •  Genomic DNA Purification Kit
        •  Viral RNA/DNA Purification Kit
        •  Plant DNA Purification Kit
        •  Microbiome DNA Purification Kit
        •  Others
      • Reagent-Based Kit
    •  RNA Isolation & Purification Kits
      • Magnetic Bead-Based Kit
        • Viral/Pathogen Nucleic Acid Isolation Kit
        • mRNA Purification Kit
        • Plant RNA Isolation Kit
        • Cell-Free Nucleic Acid Isolation Kit
        • Others
      • Column-Based Kit
        • RNA Isolation Kit
        • Mi RNA Isolation Kit
        • Viral RNA/DNA Kit
      • Reagent-Based Kit
    •  Viral Nucleic Acid Isolation kits
      • Magnetic Bead-Based Kits
      • Viral Spin-Column Kits
    •  Plasmid Purification Kit
    •  PCR and Gel kit
    •  Others
  •  Reagents
    • DNA Isolation Reagent
    • RNA Isolation Reagent
    • Others

Method

  • Magnetic Bead-Based Isolation and Purification
  • Column -Based Isolation and Purification
  • Reagent-Based Isolation and Purification
  • Others

Type

  •  Next Generation Sequencing (NGS)
  •  Genomic DNA Isolation and Purification
  •  Total RNA Isolation and Purification
  •  PCR Clean-Up
  •  Plasmid DNA Isolation and Purification
  •  Messenger RNA Isolation and Purification
  •  Circulating Nucleic Acid Isolation and Purification
  •  MicroRNA Isolation and Purification
  •  Others

Application

  •  Diagnostics
    •  Instruments
    •  Kits
    •  Reagents
  •  Drug Discovery and Development
    •  Instruments
    •  Kits
    •  Reagents
  •  Personalized Medicine
    •  Instruments
    •  Kits
    •  Reagents
  •  Agriculture and Animal Research
    •  Instruments
    •  Kits
    •  Reagents
  •  Others

Sample Type

  •  FFPE Samples
  •  Blood Cells
  •  Bacteria, Yeast, and Plants
  •  Cell-Free Samples
  •  Cultured Cells
  •  Mammalian Cells
  •  Brain and Kidney Tissue
  •  Others

End User

  • Hospitals and Diagnostic Centers
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Contract Development and manufacturing Organization (CDMO)
  • Academic/Research Institutes
  • Others

Nucleic Acid Isolation and Purification Market Regional Analysis

The market is analyzed and market size insights and trends are provided by product, method, type, application, sample type, end user, as referenced above.

The countries covered in the market are South Africa, Saudi Arabia, U.A.E., Qatar, Egypt, Kuwait, Bahrain, Oman, Rest of Middle East and Africa.

South Africa holds the largest share of the market and is expected to witness the fastest growth due to rapid advancements in healthcare infrastructure and increased investments in research and development across the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Nucleic Acid Isolation and Purification Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, regional presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Nucleic Acid Isolation and Purification Market Leaders Operating in the Market Are:

  • Merck KGaA (Germany)
  • Cutiva (Danaher Corporation) (U.S.)
  • Meridian Bioscience, Inc. (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Agilent Technologies, Inc. (U.S.)
  • PerkinElmer Inc. (U.S.)
  • Illumina Inc. (U.S.)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Thermo Fisher Scientific Inc. (U.S.)
  • QIAGEN (Netherlands)
  • Takara Bio Inc. (Japan)
  • Promega Corporation (U.S.)
  • MACHEREY-NAGEL GmbH & Co. KG (Germany)
  • New England Biolabs (U.S.)
  • Omega Bio-tek, Inc. (U.S.)
  • Zymo Research Corporation (U.S.)
  • Analytik Jena GmbH+Co. KG (Germany)
  • MagGenome Technologies Pvt. Ltd. (India)
  • AUTOGEN INC. (U.S.)
  • Xi'an Tianlong Science and Technology Co., Ltd. (China)
  • PCR Biosystems (UK)
  • Sage Science, Inc. (U.S.)
  • ALS (Australia)

Latest Developments in Nucleic Acid Isolation and Purification Market

  • In August 2024, Bio-Rad had launched the VeriCheck ddPCR Empty Full Capsid Kit, designed to enhance the development of safe and effective gene therapies. This high-precision kit enables accurate quantification of viral capsids, improving research and quality control in gene therapy applications
  • In May 2024, Thermo, Fisher and BRIN have partnered to enhance research capabilities in Indonesia, focusing on advancing scientific innovation and collaboration in life sciences, biotechnology, and environmental studies for local researchers
  • In September 2021, PerkinElmer, Inc. has successfully completed its acquisition of BioLegend for approximately USD 5.25 billion, marking its largest acquisition to date. This strategic move enhances PerkinElmer's life sciences portfolio in areas like cytometry and proteogenomics. Leaders from both companies anticipate collaborative innovation that will drive new therapeutic discoveries and advance scientific research
  • In March 2025, Medtronic announced that it had been recognized by Ethisphere, a leader in defining and advancing the standards of ethical business practices, as one of the 2025 World's Most Ethical Companies opens a new window. This helped the organization develop a brand image among other leaders
  • In April 2022, GE HealthCare. announced receiving the FDA pre-market approval (PMA) for its End-tidal (Et) Control software for general anesthesia delivery on its Aisys CS2Anesthesia Delivery System. This increased the company's product portfolio and overall revenue

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET

1.4 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 MARKET END USER COVERAGE GRID

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHT

4.1 PESTAL ANALYSIS

4.2 PORTERS FIVE FORCES ANALYSIS

4.3 ADDITIONAL CUSTOMIZATION

5 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: REGULATIONS

5.1 REGULATORY AUTHORITIES IN THE ASIA-PACIFIC REGION

5.1.1 CHINA

5.1.2 AUSTRALIA

5.1.3 INDIA

5.2 NORTH AMERICA REGULATORY SCENARIO

5.2.1 U.S.

5.2.2 CANADA

5.3 EUROPE REGULATORY SCENARIO

5.4 REGULATORY SUBMISSIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING PREVALENCE OF GENETIC DISORDERS

6.1.2 INCREASING DEMAND FOR DIAGNOSTIC TESTING

6.1.3 RISING INVESTMENT IN GENOMICS RESEARCH

6.1.4 INCREASE IN LAUNCH OF DIAGNOSTIC PRODUCTS

6.2 RESTRAINTS

6.2.1 RISKS ASSOCIATED WITH SAMPLE CONTAMINATION

6.2.2 HIGH COST OF EQUIPMENT AND REAGENTS

6.3 OPPORTUNITIES

6.3.1 RISE IN TECHNOLOGICAL ADVANCEMENTS AND AUTOMATION

6.3.2 INCREASING ADOPTION OF NEXT-GENERATION SEQUENCING (NGS)

6.3.3 GROWING APPLICATIONS IN LIQUID BIOPSY

6.4 CHALLENGES

6.4.1 TECHNICAL CHALLENGES IN SPECIFIC SAMPLE TYPES

6.4.2 ENVIRONMENTAL AND SUSTAINABILITY CONCERNS

7 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE

7.1 OVERVIEW

7.2 NEXT GENERATION SEQUENCING (NGS)

7.3 GENOMIC DNA ISOLATION AND PURIFICATION

7.4 TOTAL RNA ISOLATION AND PURIFICATION

7.5 PCR CLEAN-UP

7.6 PLASMID DNA ISOLATION AND PURIFICATION

7.7 MESSENGER RNA ISOLATION AND PURIFICATION

7.8 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION

7.9 MICRORNA ISOLATION AND PURIFICATION

7.1 OTHERS

8 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT

8.1 OVERVIEW

8.2 INSTRUMENTS

8.3 KITS

8.4 REAGENTS

9 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE

9.1 OVERVIEW

9.2 FFPE SAMPLES

9.3 BLOOD CELLS

9.4 BACTERIA, YEAST, AND PLANTS

9.5 CELL-FREE SAMPLES

9.6 CULTURED CELLS

9.7 MAMMALIAN CELLS

9.8 BRAIN AND KIDNEY TISSUE

9.9 OTHERS

10 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD

10.1 OVERVIEW

10.2 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION

10.3 COLUMN -BASED ISOLATION AND PURIFICATION

10.4 REAGENT-BASED ISOLATION AND PURIFICATION

10.5 OTHERS

11 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION

11.1 OVERVIEW

11.2 DIAGNOSTICS

11.3 DRUG DISCOVERY AND DEVELOPMENT

11.4 PERSONALIZED MEDICINE

11.5 AGRICULTURE AND ANIMAL RESEARCH

11.6 OTHERS

12 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER

12.1 OVERVIEW

12.2 HOSPITALS AND DIAGNOSTIC CENTERS

12.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES

12.4 CONTRACT RESEARCH ORGANIZATIONS

12.5 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO)

12.6 ACADEMIC/RESEARCH INSTITUTES

12.7 OTHERS

13 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION

13.1 MIDDLE EAST AND AFRICA

13.1.1 SOUTH AFRICA

13.1.2 SAUDI ARABIA

13.1.3 U.A.E.

13.1.4 QATAR

13.1.5 EGYPT

13.1.6 KUWAIT

13.1.7 BAHRAIN

13.1.8 OMAN

13.1.9 REST OF MIDDLE EAST AND AFRICA

14 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

15 SWOT ANALYSIS

16 COMPANY PROFILES

16.1 MERCK KGAA

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.5 RECENT DEVELOPMENT

16.2 CYTIVA (DANAHER CORPORATION)

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 PRODUCT PORTFOLIO

16.2.5 RECENT DEVELOPMENT

16.3 MERIDIAN BIOSCIENCE, INC.

16.3.1 COMPANY SNAPSHOT

16.3.2 COMPANY SHARE ANALYSIS

16.3.3 PRODUCT PORTFOLIO

16.3.4 RECENT DEVELOPMENT

16.4 BIO-RAD LABORATORIES, INC.

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 COMPANY SHARE ANALYSIS

16.4.4 PRODUCT PORTFOLIO

16.4.5 RECENT DEVELOPMENT

16.5 AGILENT TECHNOLOGIES, INC.

16.5.1 COMPANY SNAPSHOT

16.5.2 REVENUE ANALYSIS

16.5.3 COMPANY SHARE ANALYSIS

16.5.4 PRODUCT PORTFOLIO

16.5.5 RECENT UPDATES

16.6 AUTOGEN, INC.

16.6.1 COMPANY SNAPSHOT

16.6.2 PRODUCT PORTFOLIO

16.6.3 RECENT DEVELOPMENT

16.7 ALS

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.3 RECENT DEVELOPMENTS

16.8 ANALYTIK JENA GMBH+CO. KG

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCT PORTFOLIO

16.8.3 RECENT DEVELOPMENT

16.9 F. HOFFMANN-LA ROCHE LTD.

16.9.1 COMPANY SNAPSHOT

16.9.2 REVENUE ANALYSIS

16.9.3 PRODUCT PORTFOLIO

16.9.4 RECENT DEVELOPMENT

16.1 ILLUMINA, INC.

16.10.1 COMPANY SNAPSHOT

16.10.2 REVENUE ANALYSIS

16.10.3 PRODUCT PORTFOLIO

16.10.4 RECENT DEVELOPMENT

16.11 MAGGENOME TECHNOLOGIES PVT. LTD.

16.11.1 COMPANY SNAPSHOT

16.11.2 PRODUCT PORTFOLIO

16.11.3 RECENT DEVELOPMENT

16.12 MACHEREY-NAGEL GMBH & CO. KG

16.12.1 COMPANY SNAPSHOT

16.12.2 PRODUCT PORTFOLIO

16.12.3 RECENT DEVELOPMENT

16.13 NEW ENGLAND BIOLABS

16.13.1 COMPANY SNAPSHOT

16.13.2 PRODUCT PORTFOLIO

16.13.3 RECENT DEVELOPMENT

16.14 OMEGA BIO-TEK, INC.

16.14.1 COMPANY SNAPSHOT

16.14.2 PRODUCT PORTFOLIO

16.14.3 RECENT DEVELOPMENTS

16.15 PROMEGA CORPORATION

16.15.1 COMPANY SNAPSHOT

16.15.2 PRODUCT PORTFOLIO

16.15.3 RECENT DEVELOPMENT

16.16 PERKINELMER INC

16.16.1 COMPANY SNAPSHOT

16.16.2 REVENUE ANALYSIS

16.16.3 PRODUCT PORTFOLIO

16.16.4 RECENT DEVELOPMENT

16.17 PCR BIOSYSTEMS

16.17.1 COMPANY SNAPSHOT

16.17.2 PRODUCT PORTFOLIO

16.17.3 RECENT DEVELOPMENTS

16.18 QIAGEN

16.18.1 COMPANY SNAPSHOT

16.18.2 REVENUE ANALYSIS

16.18.3 PRODUCT PORTFOLIO

16.18.4 RECENT DEVELOPMENTS

16.19 SAGE SCIENCE, INC.

16.19.1 COMPANY SNAPSHOT

16.19.2 PRODUCT PORTFOLIO

16.19.3 RECENT DEVELOPMENTS

16.2 THERMO FISHER SCIENTIFIC INC.

16.20.1 COMPANY SNAPSHOT

16.20.2 REVENUE ANALYSIS

16.20.3 PRODUCT PORTFOLIO

16.20.4 RECENT DEVELOPMENT

16.21 TAKARA BIO INC.

16.21.1 COMPANY SNAPSHOT

16.21.2 REVENUE ANALYSIS

16.21.3 PRODUCT PORTFOLIO

16.21.4 RECENT DEVELOPMENTS

16.22 XI'AN TIANLONG SCIENCE AND TECHNOLOGY CO., LTD

16.22.1 COMPANY SNAPSHOT

16.22.2 PRODUCT PORTFOLIO

16.22.3 RECENT DEVELOPMENT

16.23 ZYMO RESEARCH CORPORATION

16.23.1 COMPANY SNAPSHOT

16.23.2 PRODUCT PORTFOLIO

16.23.3 RECENT DEVELOPMENT

17 QUESTIONNAIRE

18 RELATED REPORTS

List of Table

TABLE 1 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 2 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 3 MIDDLE EAST AND AFRICA GENOMIC DNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 4 MIDDLE EAST AND AFRICA TOTAL RNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 5 MIDDLE EAST AND AFRICA PCR CLEAN-UP IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 6 MIDDLE EAST AND AFRICA PLASMID DNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 7 MIDDLE EAST AND AFRICA MESSENGER RNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 8 MIDDLE EAST AND AFRICA CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 9 MIDDLE EAST AND AFRICA MICRORNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 10 MIDDLE EAST AND AFRICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 11 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 12 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 13 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 14 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 15 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 16 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 17 MIDDLE EAST AND AFRICA KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 18 MIDDLE EAST AND AFRICA KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 19 MIDDLE EAST AND AFRICA DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 20 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 21 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 22 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 23 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 24 MIDDLE EAST AND AFRICA RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 25 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 26 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 27 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 28 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 29 MIDDLE EAST AND AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 30 MIDDLE EAST AND AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 31 MIDDLE EAST AND AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 32 MIDDLE EAST AND AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 33 MIDDLE EAST AND AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 34 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 35 MIDDLE EAST AND AFRICA FFPE SAMPLES IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 36 MIDDLE EAST AND AFRICA BLOOD CELLS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 37 MIDDLE EAST AND AFRICA BACTERIA, YEAST, AND PLANTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 38 MIDDLE EAST AND AFRICA CELL-FREE SAMPLES IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 39 MIDDLE EAST AND AFRICA CULTURED CELLS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 40 MIDDLE EAST AND AFRICA MAMMALIAN CELLS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 41 MIDDLE EAST AND AFRICA BRAIN AND KIDNEY TISSUE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 42 MIDDLE EAST AND AFRICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 43 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 44 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 45 MIDDLE EAST AND AFRICA COLUMN-BASED ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 46 MIDDLE EAST AND AFRICA REAGENT-BASED ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 47 MIDDLE EAST AND AFRICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 48 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 49 MIDDLE EAST AND AFRICA DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 50 MIDDLE EAST AND AFRICA DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 51 MIDDLE EAST AND AFRICA DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 52 MIDDLE EAST AND AFRICA DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 53 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 54 MIDDLE EAST AND AFRICA PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 55 MIDDLE EAST AND AFRICA AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 56 MIDDLE EAST AND AFRICA AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 57 MIDDLE EAST AND AFRICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 58 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 59 MIDDLE EAST AND AFRICA HOSPITALS AND DIAGNOSTIC CENTERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 60 MIDDLE EAST AND AFRICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 61 MIDDLE EAST AND AFRICA CONTRACT RESEARCH ORGANIZATIONS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 62 MIDDLE EAST AND AFRICA CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO) IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 63 MIDDLE EAST AND AFRICA ACADEMIC/RESEARCH INSTITUTES IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 64 MIDDLE EAST AND AFRICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 65 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 66 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 67 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 68 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 69 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 70 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 71 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 72 MIDDLE EAST AND AFRICA KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 73 MIDDLE EAST AND AFRICA DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 74 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 75 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 76 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 77 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 78 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 79 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 80 MIDDLE EAST AND AFRICA RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 81 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 82 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 83 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 84 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 85 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 86 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 87 MIDDLE EAST AND AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 88 MIDDLE EAST AND AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 89 MIDDLE EAST AND AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 90 MIDDLE EAST AND AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 91 MIDDLE EAST AND AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 92 MIDDLE EAST AND AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 93 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 94 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 95 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 96 MIDDLE EAST AND AFRICA DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 97 MIDDLE EAST AND AFRICA DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 98 MIDDLE EAST AND AFRICA PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 99 MIDDLE EAST AND AFRICA AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 100 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 101 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 102 SOUTH AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 103 SOUTH AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 104 SOUTH AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 105 SOUTH AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 106 SOUTH AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 107 SOUTH AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 108 SOUTH AFRICA KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 109 SOUTH AFRICA DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 110 SOUTH AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 111 SOUTH AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 112 SOUTH AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 113 SOUTH AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 114 SOUTH AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 115 SOUTH AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 116 SOUTH AFRICA RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 117 SOUTH AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 118 SOUTH AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 119 SOUTH AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 120 SOUTH AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 121 SOUTH AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 122 SOUTH AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 123 SOUTH AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 124 SOUTH AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 125 SOUTH AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 126 SOUTH AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 127 SOUTH AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 128 SOUTH AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 129 SOUTH AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 130 SOUTH AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 131 SOUTH AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 132 SOUTH AFRICA DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 133 SOUTH AFRICA DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 134 SOUTH AFRICA PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 135 SOUTH AFRICA AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 136 SOUTH AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 137 SOUTH AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 138 SAUDI ARABIA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 139 SAUDI ARABIA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 140 SAUDI ARABIA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 141 SAUDI ARABIA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 142 SAUDI ARABIA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 143 SAUDI ARABIA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 144 SAUDI ARABIA KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 145 SAUDI ARABIA DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 146 SAUDI ARABIA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 147 SAUDI ARABIA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 148 SAUDI ARABIA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 149 SAUDI ARABIA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 150 SAUDI ARABIA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 151 SAUDI ARABIA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 152 SAUDI ARABIA RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 153 SAUDI ARABIA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 154 SAUDI ARABIA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 155 SAUDI ARABIA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 156 SAUDI ARABIA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 157 SAUDI ARABIA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 158 SAUDI ARABIA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 159 SAUDI ARABIA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 160 SAUDI ARABIA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 161 SAUDI ARABIA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 162 SAUDI ARABIA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 163 SAUDI ARABIA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 164 SAUDI ARABIA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 165 SAUDI ARABIA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 166 SAUDI ARABIA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 167 SAUDI ARABIA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 168 SAUDI ARABIA DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 169 SAUDI ARABIA DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 170 SAUDI ARABIA PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 171 SAUDI ARABIA AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 172 SAUDI ARABIA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 173 SAUDI ARABIA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 174 U.A.E. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 175 U.A.E. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 176 U.A.E. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 177 U.A.E. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 178 U.A.E. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 179 U.A.E. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 180 U.A.E. KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 181 U.A.E. DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 182 U.A.E. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 183 U.A.E. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 184 U.A.E. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 185 U.A.E. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 186 U.A.E. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 187 U.A.E. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 188 U.A.E. RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 189 U.A.E. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 190 U.A.E. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 191 U.A.E. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 192 U.A.E. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 193 U.A.E. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 194 U.A.E. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 195 U.A.E. VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 196 U.A.E. VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 197 U.A.E. VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 198 U.A.E. REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 199 U.A.E. REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 200 U.A.E. REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 201 U.A.E. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 202 U.A.E. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 203 U.A.E. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 204 U.A.E. DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 205 U.A.E. DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 206 U.A.E. PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 207 U.A.E. AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 208 U.A.E. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 209 U.A.E. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 210 QATAR NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 211 QATAR INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 212 QATAR INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 213 QATAR INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 214 QATAR INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 215 QATAR INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 216 QATAR KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 217 QATAR DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 218 QATAR MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 219 QATAR MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 220 QATAR MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 221 QATAR COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 222 QATAR COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 223 QATAR COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 224 QATAR RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 225 QATAR MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 226 QATAR MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 227 QATAR MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 228 QATAR COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 229 QATAR COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 230 QATAR COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 231 QATAR VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 232 QATAR VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 233 QATAR VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 234 QATAR REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 235 QATAR REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 236 QATAR REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 237 QATAR NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 238 QATAR NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 239 QATAR NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 240 QATAR DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 241 QATAR DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 242 QATAR PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 243 QATAR AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 244 QATAR NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 245 QATAR NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 246 EGYPT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 247 EGYPT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 248 EGYPT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 249 EGYPT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 250 EGYPT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 251 EGYPT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 252 EGYPT KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 253 EGYPT DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 254 EGYPT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 255 EGYPT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 256 EGYPT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 257 EGYPT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 258 EGYPT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 259 EGYPT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 260 EGYPT RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 261 EGYPT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 262 EGYPT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 263 EGYPT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 264 EGYPT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 265 EGYPT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 266 EGYPT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 267 EGYPT VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 268 EGYPT VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 269 EGYPT VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 270 EGYPT REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 271 EGYPT REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 272 EGYPT REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 273 EGYPT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 274 EGYPT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 275 EGYPT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 276 EGYPT DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 277 EGYPT DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 278 EGYPT PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 279 EGYPT AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 280 EGYPT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 281 EGYPT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 282 KUWAIT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 283 KUWAIT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 284 KUWAIT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 285 KUWAIT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 286 KUWAIT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 287 KUWAIT KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 288 KUWAIT DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 289 KUWAIT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 290 KUWAIT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 291 KUWAIT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 292 KUWAIT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 293 KUWAIT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 294 KUWAIT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 295 KUWAIT RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 296 KUWAIT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 297 KUWAIT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 298 KUWAIT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 299 KUWAIT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 300 KUWAIT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 301 KUWAIT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 302 KUWAIT VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 303 KUWAIT VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 304 KUWAIT VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 305 KUWAIT REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 306 KUWAIT REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 307 KUWAIT REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 308 KUWAIT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 309 KUWAIT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 310 KUWAIT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 311 KUWAIT DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 312 KUWAIT DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 313 KUWAIT PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 314 KUWAIT AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 315 KUWAIT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 316 KUWAIT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 317 BAHRAIN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 318 BAHRAIN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 319 BAHRAIN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 320 BAHRAIN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 321 BAHRAIN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 322 BAHRAIN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 323 BAHRAIN KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 324 BAHRAIN DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 325 BAHRAIN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 326 BAHRAIN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 327 BAHRAIN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 328 BAHRAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 329 BAHRAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 330 BAHRAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 331 BAHRAIN RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 332 BAHRAIN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 333 BAHRAIN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 334 BAHRAIN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 335 BAHRAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 336 BAHRAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 337 BAHRAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 338 BAHRAIN VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 339 BAHRAIN VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 340 BAHRAIN VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 341 BAHRAIN REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 342 BAHRAIN REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 343 BAHRAIN REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 344 BAHRAIN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 345 BAHRAIN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 346 BAHRAIN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 347 BAHRAIN DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 348 BAHRAIN DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 349 BAHRAIN PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 350 BAHRAIN AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 351 BAHRAIN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 352 BAHRAIN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 353 OMAN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 354 OMAN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 355 OMAN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 356 OMAN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 357 OMAN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 358 OMAN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 359 OMAN KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 360 OMAN DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 361 OMAN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 362 OMAN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 363 OMAN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 364 OMAN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 365 OMAN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 366 OMAN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 367 OMAN RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 368 OMAN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 369 OMAN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 370 OMAN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 371 OMAN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 372 OMAN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 373 OMAN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 374 OMAN VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 375 OMAN VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 376 OMAN VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 377 OMAN REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 378 OMAN REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 379 OMAN REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 380 OMAN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 381 OMAN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 382 OMAN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 383 OMAN DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 384 OMAN DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 385 OMAN PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 386 OMAN AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 387 OMAN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 388 OMAN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 389 REST OF MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

List of Figure

FIGURE 1 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: MULTIVARIATE MODELLING

FIGURE 7 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DBMR MARKET POSITION GRID

FIGURE 9 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: MARKET END USER COVERAGE GRID

FIGURE 11 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: SEGMENTATION

FIGURE 12 THREE SEGMENTS COMPRISE THE MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT

FIGURE 13 EXECUTIVE SUMMARY

FIGURE 14 STRATEGIC DECISIONS

FIGURE 15 INCREASING PREVALENCE OF GENERIC DISORDERS AND RISING INVESTMENT IN GENOMICS RESEARCH ARE PROJECTED TO EXPAND THE SCOPE OF MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET

FIGURE 16 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET IN 2025 & 2032

FIGURE 17 RNA ISOLATION & PURIFICATION KITS

FIGURE 18 DNA ISOLATION & PURIFICATION KITS

FIGURE 19 VIRAL NUCLEIC ACID ISOLATION KITS

FIGURE 20 PLASMID PURIFICATION KITS

FIGURE 21 PCR AND GEL CLEAN UP KITS

FIGURE 22 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET

FIGURE 23 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE, 2024

FIGURE 24 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE, 2025-2032 (USD THOUSAND)

FIGURE 25 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE, CAGR (2025-2032)

FIGURE 26 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE, LIFELINE CURVE

FIGURE 27 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY PRODUCT, 2024

FIGURE 28 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY PRODUCT, 2025-2032 (USD THOUSAND)

FIGURE 29 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY PRODUCT, CAGR (2025-2032)

FIGURE 30 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 31 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY SAMPLE TYPE, 2024

FIGURE 32 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY SAMPLE TYPE, 2025-2032 (USD THOUSAND)

FIGURE 33 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY SAMPLE TYPE, CAGR (2025-2032)

FIGURE 34 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY SAMPLE TYPE, LIFELINE CURVE

FIGURE 35 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY METHOD, 2024

FIGURE 36 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY METHOD, 2025-2032 (USD THOUSAND)

FIGURE 37 MIDDLE EAST AND AFRICA ANTI- NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY METHOD, CAGR (2025-2032)

FIGURE 38 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY METHOD, LIFELINE CURVE

FIGURE 39 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY APPLICATION, 2024

FIGURE 40 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY APPLICATION, 2025-2032 (USD THOUSAND)

FIGURE 41 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY APPLICATION, CAGR (2025-2032)

FIGURE 42 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 43 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY END USER, 2024

FIGURE 44 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY END USER, 2025-2032 (USD THOUSAND)

FIGURE 45 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY END USER, CAGR (2025-2032)

FIGURE 46 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY END USER, LIFELINE CURVE

FIGURE 47 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: SNAPSHOT (2024)

FIGURE 48 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY SHARE 2024 (%)

View Detailed Information Right Arrow

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on Middle East and Africa Nucleic Acid Isolation and Purification Market Segmentation, By Product (Instruments, Kits, and Reagents), Method (Magnetic Bead-Based Isolation and Purification, Column -Based Isolation and Purification, Reagent-Based Isolation and Purification, and Others), Type (Next Generation Sequencing (NGS), Genomic DNA Isolation and Purification, Total RNA Isolation and Purification, PCR Clean-Up, Plasmid DNA Isolation and Purification, Messenger RNA Isolation and Purification, Circulating Nucleic Acid Isolation and Purification, MicroRNA Isolation and Purification, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research, and Others), Sample Type (FFPE Samples, Blood Cells, Bacteria, Yeast, and Plants, Cell-Free Samples, Cultured Cells, Mammalian Cells, Brain and Kidney Tissue, and Others), End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Contract Development and manufacturing Organization (CDMO), Academic/Research Institutes, and Others) - Industry Trends and Forecast to 2032 .
The Middle East And Africa Nucleic Acid Isolation Purification Market size was valued at USD 225.03 USD Million in 2024.
The Middle East And Africa Nucleic Acid Isolation Purification Market is projected to grow at a CAGR of 8% during the forecast period of 2025 to 2032.
The market report covers data from the South Africa, Saudi Arabia, U.A.E., Qatar, Egypt, Kuwait, Bahrain, Oman, Rest of Middle East and Africa.

Browse Related Pages

Banner